ARCHIVES

A Take-Home Message From ASCO 2014: NCI-Funded Clinical Research In Jeopardy,bSociety Focuses on Value of NCTN Groups

This article is from The Cancer Letter archive.

Vol. 40 No. 23 | June 6, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

Medenica Patients Drop Suit Against Doctors; Hospital To Be sold

August 19, 1994

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

President Obama Names Six NCAB Members

December 7, 2012